Costa L G, Murphy S D
Biochem Pharmacol. 1986 Oct 1;35(19):3383-8. doi: 10.1016/0006-2952(86)90439-9.
The alpha, beta-unsaturated carbonyl compound diethylmaleate (DEM) depletes glutathione (GSH) from liver and other tissues, and for this reason it is often used in toxicological research to study the GSH-mediated metabolism of xenobiotics. In addition to GSH depletion, however, DEM has been shown to have other nonspecific effects, such as alteration of monooxygenase activities or glycogen metabolism. In this study we found that DEM (1 ml/kg) inhibited protein synthesis in brain and liver, following in vivo administration to mice. Protein synthesis was measured as the incorporation of [3H]valine into trichloroacetic acid-precipitable material. Administration of DEM also decreased body temperature by 2-3 degrees. By increasing the environmental temperature from 22 degrees to 35 degrees the hypothermic effect of DEM was prevented, without affecting its ability to deplete GSH from brain and liver. Furthermore, when mice were maintained at 35 degrees, DEM still caused a significant decrease in protein synthesis, suggesting that this effect was only partially due to hypothermia. To test whether inhibition of protein synthesis was related to GSH depletion, groups of animals were dosed with the alpha, beta-unsaturated carbonyl phorone (diisopropylidenacetone) or the specific inhibitor of GSH synthesis, buthionine sulfoximine (BSO). Phorone decreased GSH in liver and brain; however, it had no effect on protein synthesis. BSO decreased GSH levels in liver and kidney, but not in brain, and did not have any effect on protein synthesis in any of these tissues, nor did it cause any hypothermia. Furthermore, when hepatic GSH content was decreased by in vivo administration of DEM or BSO, there was no inhibition of protein synthesis measured in vitro. These results indicate that, at the dose normally used to deplete GSH from various tissues. DEM also exerts an inhibitory effect on protein synthesis, which appears to be only partially due to its hypothermic effect, and is independent from GSH depletion. BSO, which, in our experimental conditions, lacks this and other nonspecific effects, might be a good alternative for studies aimed at characterizing the role of GSH in the metabolism and toxicity of chemicals.
α,β-不饱和羰基化合物马来酸二乙酯(DEM)可消耗肝脏和其他组织中的谷胱甘肽(GSH),因此它常用于毒理学研究,以研究GSH介导的外源化合物代谢。然而,除了消耗GSH外,DEM还被证明具有其他非特异性作用,如改变单加氧酶活性或糖原代谢。在本研究中,我们发现给小鼠体内注射DEM(1 ml/kg)后,它会抑制脑和肝脏中的蛋白质合成。蛋白质合成通过测量[3H]缬氨酸掺入三氯乙酸沉淀物质中的量来测定。注射DEM还使体温降低了2 - 3度。将环境温度从22度提高到35度可防止DEM的体温过低效应,而不影响其从脑和肝脏中消耗GSH的能力。此外,当小鼠维持在35度时,DEM仍会导致蛋白质合成显著下降,这表明这种效应仅部分归因于体温过低。为了测试蛋白质合成的抑制是否与GSH消耗有关,给动物组注射α,β-不饱和羰基佛尔酮(二异丙叉丙酮)或GSH合成的特异性抑制剂丁硫氨酸亚砜胺(BSO)。佛尔酮降低了肝脏和脑中的GSH水平;然而,它对蛋白质合成没有影响。BSO降低了肝脏和肾脏中的GSH水平,但对脑中的GSH水平没有影响,并且对这些组织中的任何一个的蛋白质合成均无影响,也未引起任何体温过低。此外,当通过体内注射DEM或BSO降低肝脏GSH含量时,体外测量未发现蛋白质合成受到抑制。这些结果表明,在通常用于从各种组织中消耗GSH的剂量下,DEM还对蛋白质合成产生抑制作用,这种作用似乎仅部分归因于其体温过低效应,并且与GSH消耗无关。在我们的实验条件下,缺乏这种及其他非特异性作用的BSO,可能是旨在表征GSH在化学物质代谢和毒性中作用的研究的良好替代品。